Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study
Shih-Ming Huang, Yen-Chao Chen, Chen Wy, Lan‐Yan Yang, Din‐Li Tsan, Ngan‐Ming Tsang, Wing‐Keen Yap, Chien-Sheng Tsai, Wai-Man Leung, Ji‐Hong Hong, Joseph Tung‐Chieh Chang, Ta‐Sen Yeh, Tsung‐Han Wu, Yi-Chan Chen, Yun‐Hsuan Lin, Bing‐Shen Huang · Journal of Cancer · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2019
Abstract
Background: In clinical trials, adjuvant therapy (AT) has been shown to improve the prognosis in patients with gastric adenocarcinoma who undergo curative gastrectomy and adequate lymph node dissection.However, the optimal timing for initiating AT is still unclear.Method: We collected data from 538 patients with stage II-III gastric cancer who underwent curative gastrectomy and AT in two tertiary hospitals from 2006 to 2013.Patients were divided into the early group (≤8 weeks, n=393) and the late group (>8 weeks, n=145), based on the interval between gastrectomy and initiation of AT.Propensity score matching was applied according to baseline characteristics.Results: After 1:1 propensity score matching, an even distribution of characteristics in both groups (143:143) was achieved.The 5-year overall survival (OS) rates were 56.6% and 40.2% in the matched early and late groups, respectively (p=0.062), while the corresponding 5-year recurrence-free survival (RFS) rates were 57.6% and 46.4%, respectively (p=0.028).The time to AT initiation was correlated with RFS and had a positive association with OS.The 5-year distant metastasis-free survival was also significantly better (HR 0.682, 95% CI 0.472-0.985,p=0.040), suggesting an early AT results in a better outcome in patients.
Conclusion:We observed that initiation of AT within 8 weeks of curative gastrectomy produces better disease control and may contribute to better overall survival.
Open the resolved locator · 10.7150/jca.27753
Metadata licence: OpenAlex metadata (CC0)